• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Oxoid dry Spot Staphytect Plus

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Oxoid dry Spot Staphytect Plussee related information
Date Initiated by FirmJuly 20, 2009
Date PostedFebruary 23, 2010
Recall Status1 Terminated 3 on April 25, 2012
Recall NumberZ-0817-2010
Recall Event ID 53553
Product Classification Kit, screening, staphylococcus aureus - Product Code JWX
ProductOxoid dry Spot Staphytect Plus, Catalog #DR0100M, 120 tests/kit. Oxoid Ltd., Wade road, Basingstoke, Hants, UK. Latex slide agglutination test for the differentiation of staphylococcus aureus by detection of clumping factor, Protein A and certain polysaccarides found in methicillin-resistant S. aureus (MRSA) from those staphylococci that do not possess these properties.
Code Information Lot Number: J055610, Exp June 2011
Recalling Firm/
Manufacturer
Remel, Inc
12076 Santa Fe Trail Dr
Lenexa KS 66215-3519
For Additional Information ContactDebbie Wyatt
913-895-4075
Manufacturer Reason
for Recall
The products may give false positive results with some non-Staphylococcus aureus strains
FDA Determined
Cause 2
Process control
ActionThermo Fischer Scientific, Remel Inc. issued letters dated July 20, 2009 via regular mail explaining the reason for recall, risks involved, and requested they discard all remaining product. A Product Inventory Checklist was enclosed to report the amount of product their customer discarded. A second letter dated October 19, 2009 was issued via certified mail. For further information, contact Thermo Fischer Scientific, Remel Inc. at 1-800-255-6730, Extension 3304185.
Quantity in Commerce27 kits
DistributionNationwide Distribution -- MN, CT, FL, GA, CA, NY, MI, MO, PA, and IL.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-